Tel Aviv 60 Companies By Enterprise Value

Current Valuation
Current ValuationEfficiencyMarket RiskExp Return
1SLGN Silgan Holdings
9.48 B
 0.15 
 1.09 
 0.16 
2PEN Penumbra
9.33 B
 0.14 
 2.31 
 0.33 
3LEVI Levi Strauss Co
8.01 B
(0.12)
 1.75 
(0.21)
4VCTR Victory Capital Holdings
5.24 B
 0.17 
 2.24 
 0.38 
5ELLO Ellomay Capital
634.08 M
 0.12 
 3.14 
 0.37 
6KMDA Kamada
277.82 M
 0.03 
 1.67 
 0.05 
7ALLT Allot Communications
158.97 M
 0.10 
 3.69 
 0.37 
8INCR INC Research Holdings
96.92 M
(0.13)
 4.52 
(0.60)
9LCTX Lineage Cell Therapeutics
85.08 M
(0.14)
 5.35 
(0.77)
10RANI Rani Therapeutics Holdings
72.62 M
(0.01)
 9.99 
(0.14)
11PRTC PureTech Health PLC
37.76 M
 0.01 
 3.33 
 0.02 
12CGEN Compugen
18 M
(0.15)
 3.52 
(0.52)
13VTNA Vetanova
12.45 M
 0.00 
 0.00 
 0.00 
14ELWS Earlyworks Co, Ltd
6.28 M
 0.06 
 11.92 
 0.67 
15MRIN Marin Software
1.86 M
(0.10)
 2.65 
(0.26)
16ORMP Oramed Pharmaceuticals
(48.75 M)
(0.02)
 2.34 
(0.06)
The analysis above is based on a 90-day investment horizon and a default level of risk. Use the Portfolio Analyzer to fine-tune all your assumptions. Check your current assumptions here.
Enterprise Value is a firm valuation proxy that approximates the current market value of a company. It is typically used to determine the takeover or merger price of a firm. Unlike Market Cap, this measure takes into account the entire liquid asset, outstanding debt, and exotic equity instruments that the company has on its balance sheet. When a takeover occurs, the parent company will have to assume the target company's liabilities but will take possession of all cash and cash equivalents. Enterprise Value can be a useful tool to compare companies with different capital structures. Long term liability and current cash or cash equivalents can have a huge impact on market valuation of a given company.